Endoscopic Submucosal Dissection and Chemoradiotherapy versus Esophagectomy for T1a-m3 or T1b Esophageal Squamous Cell Carcinoma: A Meta-analysis
Endoscopy International Open · 14.08.2026 · 14 (CP)
DOI: 10.1055/a-2926-4315 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endoscopy International Open, erschienen am 14.08.2026. Verfasst von Jurandir B da Cruz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gastrointestinal Endoscopy UnitDepartment of GastroenterologyHospital das Clínicas (HCFMUSP), University of São Paulo School of MedicineSão PauloSão …. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background and Study Aims Esophagectomy is the standard treatment for superficial esophageal squamous cell carcinoma (ESCC) but carries substantial morbidity. Endoscopic submucosal dissection (ESD) followed by adjuvant chemoradiotherapy (CRT) is an organ-preserving alternative, but its oncologic efficacy in T1aM3 disease with lymphovascular invasion (LVI) and in T1b disease remains uncertain. We compared ESD+CRT with esophagectomy for these lesions. Patients and Methods Medline, Embase, and Google Scholar were searched through June 2024 (PROSPERO CRD42024593581). Primary endpoints were the risk differences (RDs) between esophagectomy and ESD+CRT for 3-year disease-free survival (3y-DFS), 3-year overall survival (OS-3y), and 5-year OS (OS-5y); the secondary endpoint was serious adverse events (SAEs). Cumulative DFS and OS were estimated by Kaplan–Meier analysis and compared with the log-rank test.
Results
Six retrospective studies (16 centers; 306 patients treated 2002–2021; ESD+CRT n = 170, esophagectomy n = 136) were included; mean follow-up was 49.8 and 53.1 months, respectively. Baseline age, LVI, and tumor depth were comparable. Three-year DFS was similar between groups (86.4% vs. 92.6%; RD 0.92, 95% CI 0.85–1.00), as was OS at 3 years (RD −0.02, 95% CI −0.08 to 0.45) and 5 years (RD −0.09, 95% CI −0.18 to 0.01). SAEs were significantly less frequent with ESD+CRT than with esophagectomy (RD 0.55, 95% CI 0.35–0.86; p = 0.009).
Conclusions
In selected superficial ESCC, ESD+CRT achieved DFS and OS comparable to esophagectomy while significantly reducing SAEs. These retrospective data support ESD+CRT as a viable organ-preserving option, particularly for patients at high surgical risk.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastrointestinal Endoscopy UnitDepartment of GastroenterologyHospital das Clínicas (HCFMUSP), University of São Paulo School of MedicineSão PauloSão PauloBrazil.
ORCID-Profile: Jurandir B da Cruz, Vitor O Brunaldi, Matheus de Oliveira Veras, Eduardo G H de Moura
Zitieren
APA
da Cruz, J. B., Gallegos, M. M., Brunaldi, V. O., Miyajima, N. T., Campos, R., Calle, S. L., Valentim, E. S. V., de Oliveira Veras, M., & de Moura, E. G. H. (2026). Endoscopic Submucosal Dissection and Chemoradiotherapy versus Esophagectomy for T1a-m3 or T1b Esophageal Squamous Cell Carcinoma: A Meta-analysis. Endoscopy International Open, 14(CP). https://doi.org/10.1055/a-2926-4315
Vancouver
da Cruz JB, Gallegos MM, Brunaldi VO, Miyajima NT, Campos R, Calle SL, et al. Endoscopic Submucosal Dissection and Chemoradiotherapy versus Esophagectomy for T1a-m3 or T1b Esophageal Squamous Cell Carcinoma: A Meta-analysis. Endoscopy International Open. 2026;14(CP). doi:10.1055/a-2926-4315
BibTeX
@article{daCruz2026,
author = {da Cruz, Jurandir B and Gallegos, Megui M and Brunaldi, Vitor O and Miyajima, Nelson T and Campos, Rayssa and Calle, Silvia L and Valentim, Evellin S V and de Oliveira Veras, Matheus and de Moura, Eduardo G H},
title = {Endoscopic Submucosal Dissection and Chemoradiotherapy versus Esophagectomy for T1a-m3 or T1b Esophageal Squamous Cell Carcinoma: A Meta-analysis},
journal = {Endoscopy International Open},
year = {2026},
volume = {14},
number = {CP},
doi = {10.1055/a-2926-4315}
}
EUVIMED